Matches in Wikidata for { <http://www.wikidata.org/entity/Q94154006> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q94154006 description "article by Patrick Roth et al published 5 November 2018 in Neuro-Oncology" @default.
- Q94154006 description "article scientifique publié en 2018" @default.
- Q94154006 description "wetenschappelijk artikel" @default.
- Q94154006 description "наукова стаття" @default.
- Q94154006 name "RBTT-08. EORTC 1709/CCTG CE.8: A PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94154006 name "RBTT-08. EORTC 1709/CCTG CE.8: A PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94154006 type Item @default.
- Q94154006 label "RBTT-08. EORTC 1709/CCTG CE.8: A PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94154006 label "RBTT-08. EORTC 1709/CCTG CE.8: A PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94154006 prefLabel "RBTT-08. EORTC 1709/CCTG CE.8: A PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94154006 prefLabel "RBTT-08. EORTC 1709/CCTG CE.8: A PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94154006 P1433 Q94154006-C2D62AB2-3A23-4958-8CF8-2D34B91CA81D @default.
- Q94154006 P1476 Q94154006-0AAA9888-C273-4D7D-936A-A2B5F23B7B0B @default.
- Q94154006 P2093 Q94154006-1AEBC4E3-1354-4E02-B83D-813F2EBA863B @default.
- Q94154006 P2093 Q94154006-1F95BA39-DA1B-4C68-9A59-0F4EB6B9FB62 @default.
- Q94154006 P2093 Q94154006-30B28A37-61A5-401E-B285-125B12FFDE17 @default.
- Q94154006 P2093 Q94154006-3606FAC2-4C63-49EE-8F87-34DD1299639F @default.
- Q94154006 P2093 Q94154006-7D1FF082-5592-4570-944E-2EA8AEFC5EAF @default.
- Q94154006 P2093 Q94154006-8C55E77B-4AAA-40FD-B468-BE032760BBBD @default.
- Q94154006 P2093 Q94154006-940E5A3D-D35F-4A02-8DB3-D8E209273BCD @default.
- Q94154006 P2093 Q94154006-A9C8F1C2-4B37-4154-A0CF-C6793C06C2F9 @default.
- Q94154006 P2093 Q94154006-BBE63D6F-C970-4AA3-963E-87323C2A22EF @default.
- Q94154006 P2093 Q94154006-C142FA8B-BC10-4C6F-BCE0-DC24A8A45627 @default.
- Q94154006 P2093 Q94154006-C38E8917-F306-4EEF-93BA-81A87C4CBC3E @default.
- Q94154006 P2093 Q94154006-F5A25D9C-6544-48C7-B8EB-A66B76740901 @default.
- Q94154006 P2093 Q94154006-F7FF9C2C-2440-4463-AC12-5E6F8FFC7E79 @default.
- Q94154006 P304 Q94154006-47644A21-28FE-4FB2-A26A-16DE4EDAECA3 @default.
- Q94154006 P31 Q94154006-43651530-6421-4B7A-BF42-30D75D95735E @default.
- Q94154006 P356 Q94154006-0445BF17-AE02-43B1-A681-A6091701C6D6 @default.
- Q94154006 P433 Q94154006-2787C3EC-86E1-4DD8-841D-ED91C2049371 @default.
- Q94154006 P478 Q94154006-6D6A3D8E-E039-45BC-B819-17A4DE3374EA @default.
- Q94154006 P50 Q94154006-F4DEA79F-A3C2-4F48-AB6E-3551D2F9A896 @default.
- Q94154006 P577 Q94154006-81A14C3A-A046-4D2F-A612-926EA3A8BE5C @default.
- Q94154006 P921 Q94154006-3A21CEC7-AD57-45FA-84C6-1091804F40FE @default.
- Q94154006 P921 Q94154006-5B7AA85D-8747-4CBF-B72A-4AD34A7CB6C9 @default.
- Q94154006 P921 Q94154006-DB1A0EDB-987D-477C-B7A4-D1295194A5A3 @default.
- Q94154006 P932 Q94154006-A099B445-E8F3-4B87-87C2-56D0E1BE1495 @default.
- Q94154006 P356 NOY148.977 @default.
- Q94154006 P1433 Q15724471 @default.
- Q94154006 P1476 "RBTT-08. EORTC 1709/CCTG CE.8: A PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94154006 P2093 "Beatrice Fournier" @default.
- Q94154006 P2093 "Benjamin Winograd" @default.
- Q94154006 P2093 "Chris O’Callaghan" @default.
- Q94154006 P2093 "Emilie Le Rhun" @default.
- Q94154006 P2093 "Frederic Dhermain" @default.
- Q94154006 P2093 "Ileana Elias" @default.
- Q94154006 P2093 "Martin van den Bent" @default.
- Q94154006 P2093 "Maureen Vanlancker" @default.
- Q94154006 P2093 "Michael Weller" @default.
- Q94154006 P2093 "Patrick Roth" @default.
- Q94154006 P2093 "Sarah Nuyens" @default.
- Q94154006 P2093 "Thierry Gorlia" @default.
- Q94154006 P2093 "Warren Mason" @default.
- Q94154006 P304 "vi235-vi236" @default.
- Q94154006 P31 Q13442814 @default.
- Q94154006 P356 "10.1093/NEUONC/NOY148.977" @default.
- Q94154006 P433 "Suppl 6" @default.
- Q94154006 P478 "20" @default.
- Q94154006 P50 Q93118855 @default.
- Q94154006 P577 "2018-11-05T00:00:00Z" @default.
- Q94154006 P921 Q282142 @default.
- Q94154006 P921 Q425088 @default.
- Q94154006 P921 Q42824827 @default.
- Q94154006 P932 "6217655" @default.